AUROBINDO PHARMA GETS USFDA CLEARANCE FOR RALEIGH PLANT
Hyderabad, Aug.17 (RAHNUMA): Aurobindo Pharma’s Raleigh facility in North Carolina has received a major regulatory boost after the US Food and Drug Administration (USFDA) classified its inspection as Voluntary Action Indicated (VAI) and closed the inspection. The facility, operated by Aurolife Pharma LLC, manufactures inhalers, dermatology and transdermal products. The USFDA inspected the plant from […]
